If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Humalog ® (insulin lispro)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information:
Humalog Summary of Product Characteristics (SmPC)
Humalog 200 Units/ml (insulin lispro): Special precautions for disposal and other handling
Special precautions for disposal and other handling of Humalog 200 Units/ml KwikPen (prefilled pen)
for use and handling
prevent the possible transmission of disease, each pen must be used
by one patient only, even if the needle is changed. The patient
should discard the needle after every injection.
Humalog solution should be clear and colourless. Humalog should not
be used if it appears cloudy, thickened, or slightly coloured or if
solid particles are visible.
of the pre-filled pen
using the KwikPen the user manual included in the package leaflet
must be read carefully. The KwikPen has to be used as recommended in
the user manual.
should not be used if any part looks broken or damaged.
unused product or waste material should be disposed of in accordance
with local requirements.
200 Units/ml [Summary of Product Characteristics]. Utrecht, The
Netherlands: Eli Lilly Nederland B.V.
Date of Last Review:December 26, 2018
Are you satisfied with this content?
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at email@example.com